[Expression of GDNF and GDNFR-alpha mRNAs in human peripheral neuropathies].
Yamamoto
M
M
Sobue
G
G
D000818:Animals; D029721:Drosophila Proteins; D051100:Glial Cell Line-Derived Neurotrophic Factor; D051097:Glial Cell Line-Derived Neurotrophic Factor Receptors; D006801:Humans; D009414:Nerve Growth Factors; D009416:Nerve Regeneration; D009419:Nerve Tissue Proteins / Q000502:physiology / Q000627:therapeutic use; D010523:Peripheral Nervous System Diseases / Q000503:physiopathology / Q000628:therapy; D011115:Polyneuropathies / Q000503:physiopathology / Q000628:therapy; D011518:Proto-Oncogene Proteins / Q000502:physiology / Q000627:therapeutic use; D051096:Proto-Oncogene Proteins c-ret; D020794:Receptor Protein-Tyrosine Kinases / Q000502:physiology / Q000627:therapeutic use
D029721:Drosophila Proteins; C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D051097:Glial Cell Line-Derived Neurotrophic Factor Receptors; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D011518:Proto-Oncogene Proteins; D051096:Proto-Oncogene Proteins c-ret; D020794:Receptor Protein-Tyrosine Kinases; C416649:Ret protein, Drosophila